Chimeric Small Molecules for the Recruitment of Antibodies to Cancer Cells

The present invention relates to chimeric chemical compounds which are used to recruit antibodies to cancer cells, in particular, prostate cancer cells or metastasized prostate cancer cells. The compounds according to the present invention comprise an antibody binding terminus (ABT) moiety covalently bonded to a cell binding terminus(CBT) through a linker and optionally, a connector molecule.

Patents:
WO 2,009,139,863

Inventor(s): SPIEGEL DAVID [US]; MURELLI RYAN [US]; ZHANG ANDREW [US]

Type of Offer: Sale



« More Medical Patents

---